Dentsply Sirona Q2 FY26 GAAP EPS turns to profit at $0.18; net sales fall 4.1% to $898 million
XRAY•Q2 2026 results
Dentsply Sirona posted Q2 2026 net income attributable to shareholders of USD 37 million, swinging from a loss; GAAP EPS was USD 0.18.
Net sales fell 4.1% year over year to USD 898 million; GAAP gross margin widened 2.5 percentage points to 54.9%.
Adjusted EPS held at USD 0.52; adjusted EBITDA margin edged up 0.2 percentage points to 21.3%.
Cash flow, partnership and outlook
Operating cash flow rose to USD 99 million from USD 48 million, driven by about USD 44 million of tariff refunds and working-capital improvements.
The company expanded its Medline Sinclair partnership in Canada and repurchased 1.3 million shares for about USD 12 million, maintaining its 2026 net sales and adjusted EPS outlook.
